The Temporal Evolution of Distinct Skin Surface Microbiome in Asian Patients with Severe Hidradenitis Suppurativa during Effective Adalimumab Treatment

J Invest Dermatol. 2022 Mar;142(3 Pt A):740-743.e2. doi: 10.1016/j.jid.2021.07.168. Epub 2021 Aug 28.

Authors

Ting-Jung Hsu¹, Hsu-Hang Yeh², Chih-Hung Lee¹, Han-Chi Tseng³

Affiliations

¹ Department of Dermatology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
² Chen Chia-Wei Dermatology, Kaohsiung, Taiwan.
³ Department of Dermatology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan. Electronic address: perkyjoy@hotmail.com.

PMID: 34461127
DOI: 10.1016/j.jid.2021.07.168

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adalimumab / therapeutic use
Hidradenitis Suppurativa* / drug therapy
Humans
Microbiota*
Severity of Illness Index
Treatment Outcome

Substances

Adalimumab